The FDA conducted an inspection at the manufacturing facility in Virgonagar from Nov. 7 to Nov. 13, according to an exchange ...

Vijayawada: The Andhra Sugars Limited has undergone US FDA inspection at their aspirin manufacturing facility at ...

Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...

From April 8-12, the U.S. FDA had conducted a comprehensive pre-approval inspection (PAI) and cGMP audit, which concluded with zero Form 483 observations, Granules said. “The successful completion of ...

Hyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an ...

Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...

Cipla Ltd on Wednesday (November 13) announced that the US Food and Drug Administration (US FDA) has issued ... Bengaluru.

In July 2024, Checkpoint announced that the FDA accepted for review the resubmission of its BLA for cosibelimab as a complete response to the complete response letter (“CRL”) issued in December 2023 ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...